Moneycontrol PRO
you are here: HomeNewsIndia

Kerala records 19,622 new positive cases; TPR is 16.74%

Meanwhile, 22,563 persons recuperated from the disease on Monday, taking the total cured to 37,96,317.

August 30, 2021 / 07:39 PM IST
Source: Reuters

Source: Reuters

Kerala on Monday reported 19,622 new positive cases and 132 COVID-19-related deaths, taking the caseload to 40,27,030 and the death toll to 20,673.

State health minister Veena George said 1,17,216 samples were tested in the last 24 hours and the Test Positivity Rate (TPR) was 16.74 per cent.

Till now 3,13,92,529 samples have been tested in the state. Among the districts, Thrissur reported the highest number of cases today--3,177, followed by Ernakulam with 2,315 and Kozhikode 1,916.

"Out of those found infected today, 62 reached the state from outside while 18,436 contracted the disease through their contact. The source of infection of 1,061 is yet to be traced and 63 health workers are also among the infected," the minister said in a release.

Meanwhile, 22,563 persons recuperated from the disease on Monday, taking the total cured to 37,96,317. Currently, there are 2,09,493 active cases.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

According to the health department, there are 353 wards under 70 local self government bodies in the state with a weekly infection population ratio of over eight per cent.

Follow our full coverage of the coronavirus pandemic here.
first published: Aug 30, 2021 07:39 pm
ISO 27001 - BSI Assurance Mark